Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND3 pseudogene 21 (MTND3P21) is a human genomic DNA sequence that shares homology with the functional, protein-coding mitochondrial MT-ND3 gene. However, it is classified as a pseudogene, meaning it does not encode a functional protein and is generally considered non-functional. MTND3P21 is located on chromosome 1p22.1, distinct from the mitochondrial genome that encodes the canonical MT-ND3. There are no known biological functions, disease associations, drug interactions, or clinical relevance for this pseudogene. MTND3P21 is a nuclear pseudogene and should not be confused with the mitochondrial gene MT-ND3, which encodes a core subunit of complex I in the electron transport chain and is associated with multiple mitochondrial diseases. MTND3P21 has no known function, disease roles, or drug interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 pseudogene 21 (MTND3P21).